Xiaoxi S. Zhou
No. 1095 Jiefang Avenue
Wuhan, 430030, China
Wuhan, 430030, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 57 publications
Combining clinical and pathological features to explore the diagnostic challenges of marginal zone lymphoma
Journal: Zhonghua yi xue za zhi
Published: June 15, 2026
Long-term outcomes of vindesine or vincristine substitutions for vinblastine in classical Hodgkin lymphoma.
Journal: Chinese medical journal
Published: January 12, 2026
CD30 CAR-T cells in combination with anti-PD-1 camrelizumab in relapsed/refractory CD30+ lymphomas.
Journal: Journal of translational medicine
Published: December 06, 2025
Long-term follow-up demonstrates the curative potential of dual CD19/CD22 CAR-T-cell therapy alone or combined with autologous stem cell transplantation in TP53-altered relapsed/refractory B-cell non-Hodgkin lymphoma.
Journal: Signal transduction and targeted therapy
Published: July 28, 2025
CAR T-cell therapy for relapsed/refractory CD5-positive diffuse large B-cell lymphoma yields more favorable outcomes than standard therapy.
Journal: Cancer biology & medicine
Published: May 07, 2025
Durable response of primary cardiac lymphoma after autologous stem cell transplantation and sequential CAR-T therapy: a case report and literature review.
Journal: Frontiers in immunology
Published: February 22, 2025
Efficacy and safety of a novel CD19, CD22 dual-targeted fully human loop bi-CAR-T for the treatment of relapsed/refractory B cell non-Hodgkin lymphoma.
Journal: Journal of translational medicine
Published: December 30, 2024
A successful haploidentical transplantation without conditioning regimen for a relapsed/refractory multiple myeloma patient after chimeric antigen receptor T-cell therapy.
Journal: Cytotherapy
Published: June 17, 2024
Search for Rare Decays of D_{s}^{+} to Final States π^{+}e^{+}e^{-}, ρ^{+}e^{+}e^{-}, π^{+}π^{0}e^{+}e^{-}, K^{+}π^{0}e^{+}e^{-}, and K_{S}^{0}π^{+}e^{+}e^{-}.
Journal: Physical review letters
Published: April 09, 2024
CD19/CD22 CAR-T-cell cocktail therapy following autologous transplantation is an optimizing strategy for treating relapsed/refractory central nervous system lymphoma.
Journal: Experimental hematology & oncology
Published: January 24, 2024
The link between ten-eleven translocation-2 (Tet2) related clonal hematopoiesis and sequential onset of two hematologic malignancies.
Journal: Genes & diseases
Published: December 20, 2023
Last Updated: 09/26/2026